Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.
about
Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model.A novel dual-cytokine-antibody fusion protein for the treatment of CD38-positive malignancies
P2860
Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.
@en
Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.
@nl
type
label
Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.
@en
Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.
@nl
prefLabel
Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.
@en
Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.
@nl
P2093
P2860
P50
P1476
Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.
@en
P2093
Alex Soltermann
Francesca Pretto
Giovanni Pellegrini
Sarah Wulhfard
P2860
P304
P356
10.1158/1535-7163.MCT-17-0211
P577
2017-07-17T00:00:00Z